期刊文献+

海南地区宫颈癌的HPV基因型检测及其临床意义 被引量:9

Detection of HPV Genotypes of Cervical Cancer and the Clinical Significant in Hainan
下载PDF
导出
摘要 目的:通过对宫颈癌组织的HPV分型检测,了解本地区宫颈癌HPV感染率及其亚型的分布情况,并分析HPV感染与宫颈癌临床生物学行为之间的关系。方法:收集200例宫颈癌患者病灶组织标本,采用HPV分型基因芯片检测系统,同时对23种HPV亚型(18种高危型和5种低危型)进行检测。结果:①HPV阳性率94.00%,共检出HPV16(69.68%)、HPV18(16.49%)、HPV33(1.06%)、HPV45(1.60%)、HPV58(1.06%)、HPV73(0.53%)6种高危型亚型。其中HPV16+18(7.45%)、HPV16+45(1.06%)、HPV18+33(1.06%);②鳞状细胞癌的HPV检出率明显高于腺癌(P<0.05);③HPV阳性率与宫颈癌患者的年龄、临床分期、病理组织学分级、盆腔淋巴结转移、治疗后的复发差异均无统计学意义(P>0.05)。结论:本组宫颈癌的HPV感染率很高,且均为高危型,其中以16型和18型占绝对优势;HPV亚型比较局限,仅有6种;HPV多重感染并不多见;高危HPV的存在与鳞状上皮恶变关系密切。 Objective:To understand HPV prevalence and HPV genotypes distribution of cervical cancer in Hainan area though the inspection of HPV subtypes, and to analyze the relation of HPV and clinical biological behavior in cervical cancer. Methods:The tissue samples of 200 cervical cancers were collected. HPV genotyping DNA chip assay was used to detect 23 HPV genotypes simultaneously, including 18 high-risk subtypes and 5 low-risk subtypes. Results:The positive rate of HPV infection was 94.00% and all ware high-risk subtypes, including 16, 18, 33, 45, 58, and73 (HPV1669.68%, HPV18 16.49%, HPV16+ 18 7.45%, HPV45 1.59%, HPV33, 58, 16+45, 18+33 1.06%, and HPV73 0.53% ). HPV positive rate was higher in squamous cell carcinoma than in adenocaminorr~ ( P 〈0.005); The positive HPV rate had no relationship with patients' age, clinical stage, pathological grade, the metastasis of lymph nodes, and recur in cervical cancer (P〉O.05). Conclusions: HPV infection of cervical cancer is very high in these cases with all high-risk subtypes. HPV16, 18 are absolute superiority, but HPV subtypes are limited, only6 strains. Multiple-infection is not common: HPV infection was more closely with the malignance of squarnous cell.
机构地区 海南省人民医院
出处 《实用妇产科杂志》 CAS CSCD 北大核心 2009年第7期407-409,共3页 Journal of Practical Obstetrics and Gynecology
基金 海南省自然科学基金项目(编号:80463)
关键词 宫颈癌 人乳头状瘤病毒 临床生物学行为 Cervical cancer Human papillomavirus (HPV) Clinical biological behavior
  • 相关文献

参考文献10

  • 1Ferber MJ,Montoya DP,Yu C,et al.Integrations of the hepatitis B (HBV) and human pepillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancer[J].Oncogene,2003,22 (24):3813-3820.
  • 2Franceschi S.The IARC commitment to cancer prevention:the example of papillomavirus and cervical cancer[J].Recent Results Cancer Res,2005,166 (3):277-297.
  • 3Clifford GM,Smith JS,Plummer M,et al.Human papillomarvirus types in invasive cervical cancer warldwide:a meta-analysis[J].Br J Cancer,2003,88 (1):63-73.
  • 4Munoz N,Bosch FX,Sanjose S,et al.Epidemiologic calassitication of human papillomavirus types associated with cervical cancer[J].N Engl J Med,2003,348 (6):518-527.
  • 5Tjalma WA,Van Waes TR,Van Eden LE,et al.Role of human apaillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix[J].Best Pract Res Clin Obstet Gynaecol,2005,19 (4):469-483.
  • 6Boyle P,Vecchia C,Walker A,et al.HGO annual report on the results of treatment in gynecological cancer[J].J Epidemiology Biostatictes,2001,12:7-43.
  • 7Silvia Franceschi,Thangarajan Rajkumar,Salvatore Vacarella.Human papillomarvirus and risk factors for cervical cancer in chennai India:casecontrol study[J].Int J Cancer,2003,107(1):127-133.
  • 8Franco,Fduardo L,Duarte F,et al.Cervical cancer,epidemiology prevention and the role of human papillomavirus infection[J].Canadian Medical Association Joumal,2001,164 (7):1017-1025.
  • 9Uchimura NS,Ribalta JC,Focchi J,et al.Evaluation of langerhans' cells in human papillomavirus-associated squamous intraepithelial lesion of the uterine cervix[J].Clin Exp Obstet Gynecol,2004,31 (4):260-262.
  • 10赵奕,徐宝甜.人乳头瘤病毒基因与宫颈癌关系研究进展[J].国际检验医学杂志,2006,27(6):516-517. 被引量:12

二级参考文献11

  • 1Munoz N, Bosch FX, de-Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer.N Engl J Med, 2003, 348(6):518-527.
  • 2Munoz N, Bosch FX, Castellsague X, et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer, 2004, 111(2): 278-285.
  • 3Lo KW, Wong YF, Chan MK, et al. Prevalence of human papillomavirus in cervical cancer: a multicenter study in China. Int J Cancer, 2002, 100(3): 327-331.
  • 4An HJ, Cho NH, Lee SY, et al. Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method. Cancer, 2003, 97(7): 1672-1680.
  • 5Kim CJ, Jeong JK, Park M, et al. HPV oligonucleotide microarray-based detection of HPV genotypes in cervical neoplastic lesions.Gynecol Oncol, 2003, 89(2): 210-217.
  • 6Clifford GM, Smith JS, Plummer M, et al. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer, 2003, 88(1): 63-73.
  • 7Davies P, Kornegay J, Iftner T. Current methods of testing for human papillomavirus. Best Pract Res Clin Obstet Gynaecol, 2001, 15(5): 677-700.
  • 8Peyton CL, Gravitt PE, Hunt WC, et al. Determinants of genital human papillomavirus detection in a US population. J Infect Dis,2001, 183(11): 1554-1564.
  • 9Levi JE, Kleter B, Quint WG, et al. High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil. J Clin Microbiol, 2002, 40(9): 3341-3345.
  • 10Kay P, Soeters R, Nevin J, et al. High prevalence of HPV 16 in South African women with cancer of the cervix and cervical intraepithelial neoplasia. J Med Virol, 2003, 71(2): 265-273.

共引文献11

同被引文献86

引证文献9

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部